NHS Could Save Thousands Annually by Switching Children's Medicine to Tablets
Experts have estimated that the NHS could achieve substantial annual savings of £40,000 per patient by prescribing tablets instead of liquid medicine for children with a specific medical condition. This significant cost-cutting measure focuses on patients diagnosed with congenital hyperinsulinism (CHI), a rare disorder affecting blood sugar levels.
Research Findings from Great Ormond Street Hospital
Researchers at Great Ormond Street Hospital (Gosh) conducted a study involving children aged seven to thirteen with CHI. The findings revealed that these patients successfully transitioned to tablet forms of medication, with many expressing a preference for tablets over the often unpleasant taste of liquid alternatives. The study emphasised notable improvements in quality of life, as tablet administration proved easier and less disruptive to daily routines for the children.
Cost Comparison and Financial Implications
The financial disparity between the two medication forms is stark. Liquid diazoxide, commonly used to treat CHI, costs approximately £15.50 per 50mg dose. In contrast, the tablet version of the same medication is priced at just £1.15 per 50mg. This dramatic price difference underscores the potential for massive savings across the NHS if the switch is implemented more widely.
Future Assessments and Broader Applications
Gosh academics are planning further assessments to explore whether even younger patients, specifically those as young as four years old, can also safely and effectively switch to the more cost-effective tablet alternative. This initiative aligns with broader NHS efforts to optimise resources while maintaining high standards of patient care. The move could represent a pivotal step in paediatric healthcare, balancing economic efficiency with therapeutic benefits.
The transition to tablets not only promises significant financial relief for the health service but also enhances the treatment experience for young patients, fostering better adherence and overall well-being.
